Table 6.
Glycemic control and lipids at baseline and 12 weeks.
| pSMA group mean baseline (SD) | pSMA group mean post intervention (SD) | Usual care group mean baseline (SD) | Usual care group mean post intervention (SD) | P value | |
|---|---|---|---|---|---|
| Hb1Ac-NGSP (%) | 7.92 (1.09) | 7.81 (0.80) | 7.30 (0.44) | 7.5 (1.03) | 0.336† |
| Hb1Ac-IFCC (mmol/mol) | 62.89 (11.90) (11.90) (11.90) | 61.89 (8.67) | 56.25 (4.86) | 58.50 (11.41) | 0.356† |
| Mean glucose (from CGMS) (mmol/L) | 11.56 (4.06) | 10.52 (1.95) | 9.66 (2.01) | 10.37 (2.49) | 0.555‡ |
| Time in range (from CGMS) (%) | 40.89 (22.84) | 49.60 (24.23) | 60.71 (26.79) | 55.14 (30.85) | 0.296† |
| Triglycerides (mmol/L) | 1.93 (0.63) | 2.13 (1.06) | 1.71 (1.15) | 2.01 (1.03) | 0.583‡ |
| Total Cholesterol (mmol/L) | 4.13 (0.61) | 3.86 (0.66) | 3.95 (0.63) | 4.15 (0.73) | 0.025‡ |
†T2 test; ‡Mann-Whitney U test; NGSP, National Glycohemoglobin Standardization program; IFCC, International Federation of Clinical Chemistry; CGMS, Continuous Glucose Monitoring System. Bold figures represent statistically significant differences.